Egypt Bioinformatics Market Analysis Report [2022-30] I Insights10

Egypt Bioinformatics Market Analysis

$ 3999

Egypt's Bioinformatics market is projected to grow from $42.98 Mn in 2022 to $159.38 Mn by 2030, registering a CAGR of 17.8% during the forecast period of 2022 - 2030. The main factors driving the growth would be the growing application of bioinformatics and increasing bioinformatics programs by academic institutes. The market is segmented by technology and by application. Some of the major players include BiotechEgypt (EGY), Agilent Technologies, IBM Life Sciences, NEC, and Qiagen.

ID: IN10EGHS001 CATEGORY: Healthcare Services GEOGRAPHY: Egypt AUTHOR: Neha Davda

Buy Now

Egypt Bioinformatics Market Executive Summary

Egypt's Bioinformatics market is projected to grow from $42.98 Mn in 2022 to $159.38 Mn by 2030, registering a CAGR of 17.8% during the forecast period of 2022 - 2030. In 2019, the healthcare expenditure in Egypt as a percentage of GDP was 4.74% or $150 per capita. In accordance with the UN's Sustainable Development Goals (SDGs), Egypt's government is placing more emphasis on improving healthcare and population health.

The discipline of bioinformatics is the combined study of biology and information technology. Data generation, data warehousing, data mining, data management, and other techniques are used in bioinformatics. Bioinformatics software and tools are used as integrated solutions to provide statistical methodologies and data processing algorithms for applications including next-generation sequencing, modeling of genomic and proteomic structure, and three-dimensional drug discovery. The market for bioinformatics in the Middle East and Africa is expanding significantly as a result of increased investment in and interest in using computational tools and techniques for the analysis and interpretation of biological data.

egypt bioinformatics market analysis

Market Dynamics

Market Growth Drivers

The growing application of bioinformatics across a range of sectors, including healthcare, agriculture, and biotechnology, and the growing number of academic institutions offering degree programs and courses in bioinformatics, which could result in more qualified workers in the sector will drive the bioinformatics market in the country.

Market Restraints

The growth of the bioinformatics market in Egypt is constrained by the scarcity of qualified professionals in this field and the high cost of developing and implementing bioinformatics solutions, making it difficult for small and medium-sized businesses to enter the market.

Competitive Landscape

Key Players

BiotechEgypt (EGY)
Agilent Technologies
IBM Life Sciences
NEC
Qiagen

Healthcare Policies and Regulatory Landscape

Egypt's healthcare system is primarily sponsored by the government and includes both public and private healthcare providers. In Egypt, healthcare laws and policies are established by the Ministry of Health and Population. In order to provide all citizens with affordable and accessible healthcare and to advance the quality and safety of healthcare services, Egypt has implemented a number of policies and regulations. All Egyptians are intended to receive universal health coverage under the 2016-passed Universal Health Insurance Law (UHIL). All people are required by law to sign up for one of the three government-sponsored health insurance programs. The National Health Care Accreditation Law is established to improve the quality of healthcare services in Egypt. The law stipulates that in order to be accredited, healthcare providers must adhere to specified requirements. The Medical Practice Law controls the licensing and regulation of medical practitioners as well as the practice of medicine in Egypt. In Egypt, the manufacture, distribution, and sale of medications are governed by the Pharmaceutical Law, while the manufacture, distribution, and sale of medical equipment are governed by the Medical Devices Law. Both regulations stipulate that before any pharmaceuticals or gadgets can be sold in the nation, they must receive the Ministry of Health and Population's approval.

Reimbursement Scenario

In Egypt, the Ministry of Health and Population oversees most of the government's reimbursement regulations for medical services. To guarantee that citizens have access to reasonably priced healthcare, the government has enacted a number of reimbursement programs. The National Health Insurance Organization (NHIO), the Military Health Insurance Organization (MHIO), and the Public Business Sector Health Insurance Organization are the three government-sponsored health insurance programs that are required to be joined by all citizens under the Universal Health Insurance Law (UHIL), which was passed in 2016. (PBSHIO). These organizations are in charge of paying medical professionals for the services they render to people with insurance. The government determines the rates of compensation for medical services, which are based on a fee-for-service system. For low-income citizens and those who are not covered by government insurance programs, there is also a process for reimbursement for out-of-pocket expenses through the Ministry of Social Solidarity.

1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Bioinformatics Market Segmentation

By Technology (Revenue, USD Billion):

Knowledge Management Tools
Bioinformatics Platforms
Bioinformatics Services

By Application (Revenue, USD Billion):

Metabolomics
Molecular phylogenetics
Transcriptomics
Chemoinformatic & drug design
Genomics
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.